Top Ten US-FDA Approved Pharmacological Agents in 2023: A Year in Review
We come to the end of 2023. Here are top ten pharmacological agents that received US-FDA approval throughout this year, across key therapy areas: 1) Zilucoplan Zilucoplan is a complement inhibitor indicated for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive. It is available in the form of […]